ArticleBreast cancer research : BCR2021

Landscape of HER2-low metastatic breast cancer (MBC): results from the Austrian AGMT_MBC-Registry.

Simon Peter Gampenrieder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.